Table 2.

Study collective

No.	Sex	Age	Diagn.	Ventilation mode	Ventilation days	P/F ratio	ECMO	Plasmapheresis	CAT scan pattern	Survival status	Overall survival [days]
1	M	55	GPA	IV	26	64,4	Yes	Yes	NSIP+ UIP- OP+	Alive	946
2	F	61	DM	IV	18	58,8	No	No	NSIP+ UIP- OP-	Dead	21
3	M	80	GPS	IV	30	141,6	Yes	Yes	NSIP+ UIP- OP+	Dead	29
4	M	64	MPA	IV	2	69,7	No	Yes	NSIP+ UIP- OP+	Alive	363
5	M	60	MPA	IV	6	40,2	Yes	Yes	NSIP+ UIP- OP-	Alive	107
6	F	51	SSc	NIV	15	46,1	No	No	NSIP- UIP- OP-	Dead	437
7	M	36	DRESS	IV	15	54,7	Yes	No	NSIP- UIP- OP-	Dead	15
8	F	67	DM	NIV	18	99,7	No	No	NSIP+ UIP+ OP-	Dead	10
9	M	61	COP	IV	28	130,0	Yes	No	NSIP+ UIP- OP+	Dead	5
10	F	31	GPA	IV	8	130,0	No	No	NSIP- UIP- OP-	Alive	13
11	M	19	GPS	IV	9	169,2	No	Yes	NSIP- UIP- OP+	Alive	1007
12	F	56	MPA	IV	24	152,8	Yes	No	NSIP+ UIP+ OP-	Dead	27
13	F	72	GPA	IV	32	76,0	No	Yes	NSIP- UIP- OP+	Alive	1760
14	M	20	GPA	IV	5	35,0	Yes	Yes	NSIP+ UIP- OP-	Dead	2

Legend: Sex category (M = male, F = female), Age [years], ventilation mode (IV = invasive ventilation, NIV = non-invasive ventilation), absolute period of ventilation [days], the P/F ratio (i.e. partial oxygen pressure in [mmHg]/ oxygen saturation in inhaled gas [%]), the use of ECMO and Plasmapheresis, CAT scan patterns, regarding NSIP, UIP and OP as possible (+) or unlikely (-), survival status (alive/ dead) and survival since first cyclophosphamide administration [days]. Of interest, patient no. 10 was lost-to-follow-up after 13 days and discharge from hospital